A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma

Dedifferentiated liposarcoma (DDLPS) is one of the most common subtypes of soft tissue sarcoma with a highly variable clinical behavior. Despite advanced molecular approaches are exploring the genetic panorama of DDLPS progression, to date the driver genes of the aggressive clinical behavior in DDLPS have not been identified yet. Here, we used a Nanostring nCounter approach to study the gene expression profile of 60 selected genes involved in DDLPS progression, in a cohort of DDLPS with aggressive clinical behavior, in comparison to a cohort of DDLPS with indolent clinical behavior. We identified five genes whose expression is significantly and consistently altered in aggressive compared to indolent DDLPS. Moreover, by a clinical outcome analyses we found MAP3K12 gene expression linked with both a higher risk of metastases and death. We envisage that the identified genes could represent the first genes of a genetic signature able to predict the clinical evolution of a DDLPS.

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2025-03-17
DOI
https://doi.org/10.1038/s41598-025-91791-6
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma

Francesco Pantano, Angelo Paolo Dei Tos, Carla Rabitti, Simone Carotti et al.
Scientific Reports
Sarcoma Diagnosis and Treatment
article

A Nanostring gene expression approach identifies aggressive clinical behavior related genes in dedifferentiated liposarcoma

Francesco Pantano, Angelo Paolo Dei Tos, Carla Rabitti, Simone Carotti, Paolo Manca, Silvia Vallese, Giuseppe Perrone, Lorenzo Nibid, Giuseppe Tonini, Chiara Taffon, Francesca Zalfa, Marta Sbaraglia, Bruno Vincenzi, Daniela Righi
article en

Abstract

Dedifferentiated liposarcoma (DDLPS) is one of the most common subtypes of soft tissue sarcoma with a highly variable clinical behavior. Despite advanced molecular approaches are exploring the genetic panorama of DDLPS progression, to date the driver genes of the aggressive clinical behavior in DDLPS have not been identified yet. Here, we used a Nanostring nCounter approach to study the gene expression profile of 60 selected genes involved in DDLPS progression, in a cohort of DDLPS with aggressive clinical behavior, in comparison to a cohort of DDLPS with indolent clinical behavior. We identified five genes whose expression is significantly and consistently altered in aggressive compared to indolent DDLPS. Moreover, by a clinical outcome analyses we found MAP3K12 gene expression linked with both a higher risk of metastases and death. We envisage that the identified genes could represent the first genes of a genetic signature able to predict the clinical evolution of a DDLPS.

Scientific ReportsVol. 15(1)
University of Padua (IT), Università Campus Bio-Medico (IT), Bambino Gesù Children's Hospital (IT), Campus Bio Medico University Hospital (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
Università Campus Bio-Medico di Roma
Good health and well-being
Openalex Percentile: Top 93%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.